Budapest mayor calls for making results of antibody tests on Sinopharm recipients public
Gergely Karácsony, the mayor of Budapest, has sent a letter to the prime minister asking Viktor Orbán to make the results of antibody lab tests of Sinopharm vaccine recipients public, his office said on Wednesday.
Karácsony has also asked for the government to offer free antibody testing to everybody inoculated with the Chinese Covid vaccine and provide a third booster jab to those that have not developed immunity.
Karácsony has been contacted by persons who had been vaccinated with Sinopharm and asked for his help because antibody tests they took revealed that the vaccine failed to make many of them develop immunity and representatives of a group of more than three thousand people set up to share experiences with Sinopharm met the mayor on Tuesday.
The statement said that in case the government refuses to offer free antibody tests in the foreseeable future, Budapest will make the necessary arrangements to do so within its powers.
Read alsoForeign minister: New Sinopharm shipment fulfils contract with China
please make a donation here
Hot news
Hungarian methods used in the Dominican Republic against illegal migration?
Embarrassing fail: Police did not catch perpetrators of Budapest Louis Vuitton store despite their claim
PHOTOS: Hungarian Pavilion of the 60th Venice Biennale opens
NézÅ‘pont: Europeans shared surprising opinion about the EU’s crisis management
Király Thermal Bath: the iconic spa may regain its pomp with Turkish help – PHOTOS
Balázs Orbán: Guaranteeing Hungary’s security a priority
2 Comments
Personal medical data should stay persona.
It’s not about personal medical data. It wouldn’t name them. Although if these people are that concerned they may consent to their name being published. I should think it would be statistics published as a percentage or a figure out of 3000 say. Blimey the government is always publishing statistics on how successful they’ve been. Transparency is key. Always comes back to Sinopharm though and the Chinese.